Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Symbravo medication information ema europa eu?Drug patent watch trametinib?Novartis patent term dabrafenib?Dabrafenib and trametinib cost?Bortezomib market france?
See the DrugPatentWatch profile for Ilumya
Ilumya (tildrakizumab) is manufactured by the company that makes the medicine and is supplied to markets according to the manufacturer’s global production sites. The specific manufacturing location (such as a “manufactured in Germany” statement) depends on the product presentation and the labeling on the box and the package insert.
Check the wording on the carton and on the vial/label for fields such as “Manufactured by” and the stated country or site. Many drug products list the manufacturer and sometimes the manufacturing site or address directly on the packaging, and that wording will match the batch.
Brand biologics can be produced in multiple licensed facilities worldwide to meet demand and regulatory requirements. Even when the medicine is the same, different batches can come from different plants, so the country shown on the labeling can vary.
Look for: - “Manufactured by” (company name) - “Manufacturing site” or an address - Any explicit phrase like “manufactured in …” If you share what your Ilumya packaging leaflet/label says under “Manufactured by” (you can paste the line and the country shown), I can help interpret it.
Other Questions About Ilumya :